Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing...

Area of Science:

• Neuroscience
• Endocrinology
• Pharmacology

Background:

• Efficacy of estrogen action in the brain presents unresolved challenges, including optimal therapy timing, formulation, and duration.
• Thrombotic and neoplastic risks necessitate careful consideration in developing estrogen alternatives for neurodegenerative disorders and climacteric symptoms.
• Selective targeting of brain estrogen mechanisms is crucial to avoid peripheral side effects, particularly in reproductive organs.

Purpose of the Study:

• To review recent advances in estrogen action mechanisms for designing effective Neuro-SERMs.
• To explore strategies for developing molecules that promote memory function and neuronal survival.
• To identify novel approaches for preventing brain-related climacteric symptoms and neurodegenerative diseases.

Main Methods:

• Overview of molecular mechanisms of estrogen action.
• Pharmacological analysis of estrogen receptor subtypes.
• Evaluation of existing selective estrogen receptor modulators (SERMs) in neurons.

Main Results:

• Insights into designing efficacious NeuroSERMs that activate specific cellular, biochemical, and genomic events in the brain.
• Understanding the role of estrogen receptor subtypes and a potential membrane-associated splice variant in mediating estrogenic effects.
• Identification of strategies for developing novel molecules with NeuroSERM potential.

Conclusions:

• Novel molecules with NeuroSERM potential can be developed to selectively target brain estrogen mechanisms.
• These targeted therapies may prevent brain-related climacteric symptoms and neurodegenerative diseases.
• Further research into selective estrogen receptor modulation is vital for brain health.